High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunte...

por Kokolakis, Georgios, Kreis, German, Falqués, Meritxell, Aparici, Mònica, Sondermann, Wiebke
Publicado 2022

In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD p...

por Milara, Javier, Contreras, Sonia, de Diego, Alfredo, Calbet, Marta, Aparici, Mònica, Morcillo, Esteban, Miralpeix, Montserrat, Cortijo, Julio
Publicado 2019